Cargando…
Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
In the second article in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved.
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564757/ https://www.ncbi.nlm.nih.gov/pubmed/23393429 http://dx.doi.org/10.1371/journal.pmed.1001380 |
_version_ | 1782258348277628928 |
---|---|
author | Riley, Richard D. Hayden, Jill A. Steyerberg, Ewout W. Moons, Karel G. M. Abrams, Keith Kyzas, Panayiotis A. Malats, Núria Briggs, Andrew Schroter, Sara Altman, Douglas G. Hemingway, Harry |
author_facet | Riley, Richard D. Hayden, Jill A. Steyerberg, Ewout W. Moons, Karel G. M. Abrams, Keith Kyzas, Panayiotis A. Malats, Núria Briggs, Andrew Schroter, Sara Altman, Douglas G. Hemingway, Harry |
author_sort | Riley, Richard D. |
collection | PubMed |
description | In the second article in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved. |
format | Online Article Text |
id | pubmed-3564757 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35647572013-02-07 Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research Riley, Richard D. Hayden, Jill A. Steyerberg, Ewout W. Moons, Karel G. M. Abrams, Keith Kyzas, Panayiotis A. Malats, Núria Briggs, Andrew Schroter, Sara Altman, Douglas G. Hemingway, Harry PLoS Med Guidelines and Guidance In the second article in the PROGRESS series on prognostic factor research, Sara Schroter and colleagues discuss the role of prognostic factors in current clinical practice, randomised trials, and developing new interventions, and explain why and how prognostic factor research should be improved. Public Library of Science 2013-02-05 /pmc/articles/PMC3564757/ /pubmed/23393429 http://dx.doi.org/10.1371/journal.pmed.1001380 Text en © 2013 Riley et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Guidelines and Guidance Riley, Richard D. Hayden, Jill A. Steyerberg, Ewout W. Moons, Karel G. M. Abrams, Keith Kyzas, Panayiotis A. Malats, Núria Briggs, Andrew Schroter, Sara Altman, Douglas G. Hemingway, Harry Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title | Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title_full | Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title_fullStr | Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title_full_unstemmed | Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title_short | Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research |
title_sort | prognosis research strategy (progress) 2: prognostic factor research |
topic | Guidelines and Guidance |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564757/ https://www.ncbi.nlm.nih.gov/pubmed/23393429 http://dx.doi.org/10.1371/journal.pmed.1001380 |
work_keys_str_mv | AT rileyrichardd prognosisresearchstrategyprogress2prognosticfactorresearch AT haydenjilla prognosisresearchstrategyprogress2prognosticfactorresearch AT steyerbergewoutw prognosisresearchstrategyprogress2prognosticfactorresearch AT moonskarelgm prognosisresearchstrategyprogress2prognosticfactorresearch AT abramskeith prognosisresearchstrategyprogress2prognosticfactorresearch AT kyzaspanayiotisa prognosisresearchstrategyprogress2prognosticfactorresearch AT malatsnuria prognosisresearchstrategyprogress2prognosticfactorresearch AT briggsandrew prognosisresearchstrategyprogress2prognosticfactorresearch AT schrotersara prognosisresearchstrategyprogress2prognosticfactorresearch AT altmandouglasg prognosisresearchstrategyprogress2prognosticfactorresearch AT hemingwayharry prognosisresearchstrategyprogress2prognosticfactorresearch AT prognosisresearchstrategyprogress2prognosticfactorresearch |